SMT-0094

SMT-0094 is an investigational ophthalmic solution developed by Senju Pharmaceutical Co., Ltd. It has been evaluated in clinical usability studies in Japan (e.g., jRCT1080225023) to assess the ease of administration and user experience of the formulation and its delivery system in healthy volunteers. These studies typically focus on patient-centric factors such as the force required to dispense drops and the accuracy of instillation. As of current public records, the specific active pharmaceutical ingredient, biological target, and therapeutic indication for SMT-0094 have not been disclosed, though its development is centered on optimizing ophthalmic drug delivery.